CYCLERION

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Feb 2023 filing date already counts against anyone who files later.

Record

Serial number

97806491

Mark type

Word mark

Filed

22 Feb 2023

Published for opposition

09 Jan 2024

Attorney of record

Anessa O. Kramer

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, neuropsychiatric diseases, mood disorders, mental diseases, neurodegenerative diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds

Owner

• Cyclerion Therapeutics, Inc., Cambridge, MA, US
• Cyclerion Therapeutics, Inc., Cambridge, MA, US

Prosecution history

• 14 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 Oct 2026 — SOU EXTENSION 5 GRANTED
• 02 Sept 2026 — SOU EXTENSION 5 FILED
• 13 Oct 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 02 Sept 2026 — SOU TEAS EXTENSION RECEIVED
• 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 05 Feb 2026 — SOU EXTENSION 4 GRANTED
• 05 Feb 2026 — SOU EXTENSION 4 FILED
• 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
• 30 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Jul 2025 — SOU EXTENSION 3 GRANTED
• 30 Jul 2025 — SOU EXTENSION 3 FILED
• 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
• 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 13 Feb 2025 — SOU EXTENSION 2 GRANTED